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ABSTRACT
Background: Delirium and dementia are highly interrelated. However, few comprehensive epidemiological
studies have examined this altered state of consciousness superimposed on dementia. We investigated the
frequency of delirium in patients with dementia, its prevalence in patients with each dementia type, and its
association with cerebrovascular disease (CVD) in patients with neurodegenerative dementias.
Methods: We studied 261 consecutive outpatients in the memory clinic of a psychiatric hospital between April
2010 and September 2011. All patients underwent routine laboratory tests and computed tomography (CT),
and their Mini-Mental State Examination, Neuropsychiatric Inventory (NPI), Physical Self-Maintenance
Scale (PSMS), and Delirium Rating Scale – Revised 98 scores were recorded. The diagnosis of delirium was
based on the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision. CVD was
detected by CT.
Results: Among the 206 patients with dementia, delirium was present in 40 (19.4%). The proportion of
patients who experienced episodes of delirium was 14.7% in the Alzheimer’s disease, 34.4% in the vascular
dementia, 31.8% in the dementia with Lewy bodies, and none in frontotemporal lobar degeneration. Delirium
was frequently observed in patients with dementia and CVD. The NPI total and agitation subscale scores
were significantly higher in dementia patients with delirium than in those without delirium. PSMS scores were
significantly lower for patients with delirium than for patients without delirium.
Conclusions: The frequency of delirium varies with each dementia type. In addition, delirium decreases
activities of daily living, exaggerates behavioral and psychological symptoms dementia, and is associated
with CVD in patients with neurodegenerative dementias.
Key words: delirium, dementia, cerebrovascular disease, behavioral and psychological symptoms of dementia, neuropsychiatric inventory
Introduction
There is a strong interrelationship between delirium
and dementia, both pathophysiologically and
clinically (Young and Inouye, 2007). Delirium su-
perimposed on dementia is common but frequently
unrecognized, and these patients reportedly exhibit
an accelerated decline in cognitive and functional
abilities, a greater need for institutionalization,
a greater re-hospitalization risk, and increased
mortality (Fick et al., 2002).
According to a recent review article, the
prevalence of delirium in elderly individuals aged
65 years is 1–2%, and it increases up to 22% in
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elderly individuals with dementia (de Lange et al.,
2012). The prevalence of delirium superimposed on
dementia ranges from 22 to 89% in community and
hospital populations (Fick et al., 2002).
Although dementia is generally considered a
major risk factor for delirium, the relationship
between delirium and dementia remains unclear.
We hypothesized that the frequency of delirium
varies with each dementia type, and is associ-
ated with cerebrovascular disease (CVD) with
neurodegenerative dementias. This study aimed to
investigate the frequency of delirium superimposed
on dementia in patients with each dementia type
and examines the association between delirium and
CVD in patients with neurodegenerative dementias.
Methods
All procedures followed the Clinical Study
Guidelines of the Ethics Committee of Kumamoto
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Mental Health Hospital and were approved by the
internal review board. A complete description of all
procedures was provided to the patients, and written
informed consents were obtained from all patients
or their caregivers prior to participation.
This study was a prospective, dementia referral
center-based, cohort study. The participants
were 206 consecutive patients with dementia.
These patients were defined at the time of
initial assessment and selected on the basis of
inclusion/exclusion criteria from a consecutive
series of 261 patients who had undergone medical
examination at the memory clinic of Kumamoto
Mental Health Hospital from April 2010 to
September 2011. All patients were examined
by senior neuropsychiatrists (M. Ikeda and Y.
Yatabe) using routine laboratory tests, computed
tomography, and standard neuropsychological
examinations, the results of which included Mini-
Mental State Examination (MMSE; Folstein et al.,
1975) and Physical Self-Maintenance Scale (PSMS;
Lawton and Brody, 1969; Hokoishi et al., 2001)
scores. Behavioral and psychological symptoms
of dementia (BPSD) were assessed by the
Neuropsychiatric Inventory (NPI; Cummings et al.,
1994; Hirono et al., 1997). In addition, we
investigated antipsychotic and benzodiazepine use
at the time of initial assessment. We also assessed
delirium severity using the Delirium Rating Scale
– Revised 98 (DRS-R98; Trzepacz et al., 2001;
Kato et al., 2010). The DRS-R98 severity scale
score ranges from 0 to 39, with higher scores
indicating more severe delirium and a cut-off score
of15 being consistent with a diagnosis of delirium
(Meagher et al., 2010).
The diagnosis of delirium was based on the
criteria for delirium outlined in the Diagnostic and
StatisticalManual ofMental Disorders, fourth edition,
text revision (DSM-IV-TR; American Psychiatric
Association, 2000). All patients with delirium
fulfilled the following core criteria: (a) disturbance
of consciousness, (b) changes in cognition, (c)
development of disturbances over a short period of
time, with a fluctuating course during the day, and
(d) evidence from the history, physical examination,
or laboratory findings that the disturbance is caused
by the direct physiological consequence of general
medical condition or drug effect. The criteria
for delirium state that the condition should not
be better explained by a pre-existing dementia,
whereas the criteria for dementia state that prior
delirium should be excluded.
Therefore, dementia was diagnosed according
to the Diagnostic and Statistical Manual of
Mental Disorders, third edition-revised (DSM-
III-R; American Psychiatric Association, 1987)
after improvement of consciousness by clinical
treatments. If dementia existed, each dementia
type was diagnosed according to the international
consensus criteria. Patients were divided into
those with probable Alzheimer’s disease (AD),
defined according to the National Institute for
Neurological and Communicative Disorders and
Stroke and Alzheimer’s disease and Related
Disorders Association (NINCDS–ADRDA; McK-
hann et al., 1984); probable vascular dementia
(VaD), defined according to the NINCDS and
Association Internationale pour la Recherche
et l’Enseignement en Neurosciences (NINDS–
AIREN) criteria (Román et al., 1993); probable
dementia with Lewy bodies (DLB), defined
according to the consensus criteria for the
clinical diagnosis of DLB, 2005 (McKeith et al.,
2005); frontotemporal lobar degeneration (FTLD),
defined according to the international collaborative
workshop on FTLD, 1998 (Neary et al., 1998);
or other types. In patients where it was difficult
to determine whether symptoms were due to
delirium or DLB were diagnosed as DLB without
delirium. Therefore, the prevalence of delirium in
patients with DLB could have been underestimated
in this study. The presence of CVD, including
multiple lacunar infarcts and leukoencephalopathy,
was determined by a senior neuropsychiatrist (M.
Hashimoto), who was blinded to the clinical data.
As suggested by a number of previous studies
(Bennett et al., 1990; Román et al., 1993; Yoshitake
et al., 1995; Leys et al., 1999), we used a semi-
standardized measure and classified CVD on the
basis of computed tomography (CT) findings as
follows (Ikeda et al., 2001): multiple lacunar
infarcts, leukoencephalopathy with or without
lacunar infarcts, multiple infarcts, strategic single
infarct, large cortical infarcts, cerebral hemorrhage,
and subarachnoid hemorrhage.
Exclusion criteria for this study included the
following: (a) absence of dementia according
to DSM-III-R, (b) those with developmental
abnormalities, serious psychiatric diseases, such as
schizophrenia or major depression, or substance
abuse before the onset of dementia, (c) absence
of reliable informants, and (d) inability to obtain
informed consent from patient and caregiver.
Statistical differences in age, education, and
MMSE, PSMS, NPI total, and NPI subscale
scores between patients with dementia and
delirium and those with dementia without delirium
were assessed by Student’s t-tests. The χ2 for
independence test was conducted to compare sex;
presence of CVD; use of donepezil, antipsychotics,
or benzodiazepines; presence of CVD with
neurodegenerative dementias; and the prevalence
of delirium in patients with each dementia type.
A significance level of 0.05 (two-tailed) was set
for all analyses, which were conducted with SPSS
for Windows, version 17.0 (IBM Corporation,
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Table 1. Prevalence of delirium in patients with each dementia type
P A T I E N T S
(n = 206)
P A T I E N T S
W I T H
DELIRIUM
(n = 40)
DELIRIUM
I N E A C H
D E M E N T I A
T Y P E
DIAGNOSIS n % n % %
....................................................................................................................................................................................................................................
AD 129 62.6 19 47.5 14.7
(AD) (83) (40.3) (9) (22.5) (10.8)
(AD with CVD) (46) (22.3) (10) (25.0) (21.7)
VaD 32 15.5 11 27.5 34.4
DLB 22 10.7 7 17.5 31.8
(DLB) (12) (5.8) (3) (7.5) (25.0)
(DLB with CVD) (10) (4.9) (4) (10.0) (40.0)
FTLD 5 2.4 0 0 0
(FTLD) (4) (1.9) (0) (0) (0)
(FTLD with CVD) (1) (0.5) (0) (0) (0)
Others 18 8.7 3 7.5 16.7
Notes: AD: Alzheimer’s disease, CVD: cerebrovascular disease, VaD: vascular dementia, DLB:
dementia with Lewy bodies; FTLD: frontotemporal lobar degeneration.
Armonk, NY, USA). In addition, two-way analysis
of variance (ANOVA) was used to analyze the
effects of each diagnosis with or without delirium
and their interaction effects on scores for individual
items in the NPI. The significance level was
set at 0.01 or less. Scheffe’s post hoc test was
performed to detect any significant differences
between diagnoses.
Results
Among the 206 patients, there were 142 women
and 64 men with a mean age of 81.4 years
(standard deviation (SD), 6.0), a mean educational
attainment period of 8.5 years (SD, 2.1), and a
mean MMSE score of 15.9 points (SD, 6.0). AD
was observed in 62.6% (129/206) patients, VaD in
15.5% (32/206) patients, DLB in 10.7% (22/206)
patients, and FTLD in 2.4% (5/206) patients.
Forty patients (19.4%) suffered from delirium.
The frequency of delirium varied with dementia
type, as shown in Table 1. The proportion of
patients who experienced episodes of delirium was
14.7% in the AD group, 34.4% in the VaD
group, and 31.8% in the DLB group, whereas no
patient with FTLD experienced these episodes,
indicating that the prevalence of delirium was
significantly diverse for each dementia type (p =
0.022). Furthermore, delirium was more frequent
in patients with CVD than in those without (p =
0.006); 21.7% of AD with CVD and 40.0% of DLB
with CVD developed delirium, while 10.8% of AD
without CVD and 25.0% of DLB without CVD
developed delirium.
Demographic characteristics of the patients with
and without delirium are shown in Table 2. There
were no significant differences between the two
groups with regard to age, sex, education, MMSE
score, and use of donepezil, while patients with
delirium more frequently used antipsychotics and
benzodiazepines compared with those without
delirium. PSMS scores were significantly lower
for patients with delirium than for those without
delirium (p = 0.013), while DRS-R98 severity was
significantly higher for patients with delirium than
for those without delirium (p < 0.001). With regard
to NPI scores, NPI total scores (p = 0.019) and
NPI agitation subscale scores (p = 0.026) were
significantly higher for patients with delirium than
for those without delirium.
Table 3 shows scores for individual NPI sub-
scales among patients with each dementia type with
or without delirium. Two-way ANOVA revealed
statistically significant differences in scores for
hallucinations among patients with each dementia
type (p < 0.001) and in scores for agitation between
patients with and without delirium (p = 0.008).
Scheffe’s post hoc comparisons revealed that DLB
patients with delirium exhibited significantly higher
scores for hallucinations compared with AD or
VaD patients with delirium (p < 0.01). Overall, no
significant differences were observed in individual
NPI scores between patients with each dementia
type with or without delirium (p > 0.01).
Discussion
To the best of our knowledge, this is the
first study to investigate the disease-specific
frequency of delirium superimposed on dementia
on an outpatient basis. Delirium was present in
approximately 20% outpatients with dementia,
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Table 2. Demographic characteristics of patients with dementia with or without delirium
P A T I E N T S
D E M E N T I A
WITHOUT
DELIRIUM
D E M E N T I A
W I T H
DELIRIUM
(n = 206) (n = 166) (n = 40) p-VALUE
.....................................................................................................................................................................................................................................................................
Age, years (SD) 81.4 (6.0) 81.0 (6.1) 82.8 (5.3) 0.090
Male, sex, n (%) 64 (31.1) 54 (32.5) 10 (25.0) 0.356
Years of education, y (SD) 8.5 (2.1) 8.5 (2.2) 8. 3 (1.8) 0.540
MMSE (SD) 15.9 (6.0) 16.1 (6.0) 14.7 (6.1) 0.162
Treatment with donepezil (%) 40 (19. 4) 32 (19.3) 8 (20.0) 0.917
Treatment with antipsychotic
agent (%)
16 (7.8) 8 (4.8) 8 (20.0) 0.001∗
Treatment with
benzodiazepine (%)
23 (11.2) 8 (4.8) 15 (37.5) <0.001∗
PSMS (SD) 4.0 (1.9) 4.2 (1.9) 3.3 (2.1) 0.013∗
CVD, n (%) 94 (45.6) 68 (41.0) 26 (65.0) 0.006∗
DRS-R98 severity (SD) 10.8 (5.4) 8.9 (3.4) 18.5 (5.0) <0.001∗
NPI total score (SD) 11.1 (12.4) 9.8 (11.2) 16.2 (15.7) 0.019∗
NPI subscale score,
frequency × severity (SD)
Delusions 1.3 (2.5) 1.9 (2.6) 0.161
Hallucinations 0.7 (1.9) 1.2 (2.5) 0.260
Agitation 1.1 (2.3) 2.3 (3.2) 0.026∗
Dysphoria 0.8 (1.5) 1.5 (2.7) 0.114
Anxiety 1.0 (1.9) 2.0 (3.0) 0.062
Euphoria 0.1 (0.5) 0.1 (0.6) 0.807
Apathy 2.4 (2.8) 3.5 (3.9) 0.103
Disinhibition 0.4 (1.4) 0.2 (1.0) 0.426
Irritability 1.2 (2.5) 2.1 (3.5) 0.107
Aberrant motor behavior 0.9 (2.4) 1.5 (2.9) 0.265
Notes: ∗p < 0.05.
CVD: cerebrovascular disease, MMSE: Mini-Mental State Examination,
PSMS: Physical Self-Maintenance Scale, DRS-R98: Delirium Rating Scale-Revised 98, NPI: Neuropsychiatric
inventory.
although the prevalence of delirium was diverse for
each dementia type: 14.7% in patients with AD,
34.4% in patients with VaD, 31.8% in patients
with DLB, and 0% in patients with FTLD. The
prevalence of delirium among AD and DLB patients
with CVD was 1.6 times higher than that in AD
and DLB patients without CVD. The findings
suggest that delirium decreases activities of daily
living (ADL) and exaggerates BPSD in patients with
dementia.
In a study that examined patients (n = 175)
admitted to a neuropsychiatric unit (Robertsson
et al., 1998), the overall prevalence of recurrent
delirium was 37%: 57% in patients with late-
onset AD, 14% in patients with early-onset AD,
19% in patients with frontotemporal dementia, and
40% in patients with VaD. Among patients with
acute medical illness, delirium was observed in
26% patients with primary degenerative dementia
and 52% patients with dementia associated with
vascular changes, i.e., VaD (Erkinjuntti et al.,
1986). However, there have been no studies that
have investigated the prevalence of delirium in
patients with DLB. Among the patients with
neurodegenerative dementias in this study, the
prevalence of delirium was highest in the DLB
group. It can be particularly difficult to distinguish
delirium from DLB because some features such
as hallucinations and symptom fluctuation are
common to both (Young and Inouye, 2007).
In the current study, dementia was diagnosed
immediately after it was determined that the
symptoms of delirium had subsided. Moreover,
DRS-R98 severity scores were significantly higher
for DLB patients with delirium (mean, 19.6;
SD, 5.2; range, 15–28) than for DLB patients
without delirium (mean, 11.7; SD, 2.6; range, 5–
14; p = 0.006). No DLB patient with delirium
exhibited a score of <15, whereas no DLB
patient without delirium exhibited a score of 15.
DLB patients with delirium exhibited significantly
higher scores for the hallucination subscale of
the NPI compared with AD and VaD patients
with delirium. However, overall differences in
individual NPI scores among patients with each
dementia type with or without delirium were
not significant. Dementia researchers need to
assess any delirium component more carefully
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Table 3. Mean composite scores (frequency× severity) of individual Neuropsychiatric Inventory (NPI) items
among patients with each dementia type with or without delirium
T W O-WAY ANOVA;
p-VALUE
NPI
SUBSCALES
D E M E N T I A
WITHOUT
D E L I R I U M
(n = 166)
D E M E N T I A
W I T H
D E L I R I U M
(n = 40) p-VALUE
EACH
T Y P E
W I T H/WITHOUT
DELIRIUM INTERACTION
.........................................................................................................................................................................................................................................................................................................................
Delusions
AD 1.39 (2.63) 1.53 (2.53) 0.835 0.026 0.176 0.646
VaD 0.86 (1.93) 1.91 (2.17) 0.170
DLB 2.67 (2.85) 3.71 (3.30) 0.453
Hallucinations
AD 0.46 (1.67) 0.58 (1.92) 0.786 <0.001∗a 0.539 0.937
VaD 0.48 (1.21) 0.64 (1.43) 0.741
DLB 3.53 (2.90) 4.00 (3.87) 0.755
Agitation
AD 1.23 (2.46) 2.89 (3.50) 0.059 0.042 0.008∗ 0.676
VaD 0.33 (0.91) 1.09 (2.59) 0.366
DLB 1.20 (2.01) 3.00 (3.22) 0.122
Dysphoria
AD 0.88 (1.65) 1.58 (3.06) 0.344 0.635 0.117 0.987
VaD 0.62 (1.16) 1.18 (2.44) 0.381
DLB 1.07 (1.79) 1.71 (2.36) 0.483
Anxiety
AD 1.12 (2.19) 1.53 (2.97) 0.479 0.275 0.010 0.355
VaD 0.57 (1.17) 2.09 (2.63) 0.092
DLB 1.33 (1.50) 3.14 (3.93) 0.278
Euphoria
AD 0.12 (0.57) 0.00 (0.00) 0.370 0.453 0.472 0.131
VaD 0.00 (0.00) 0.36 (1.21) 0.341
DLB 0.00 (0.00) 0.00 (0.00) -
Apathy
AD 2.41 (2.79) 3.47 (4.16) 0.294 0.594 0.228 0.634
VaD 3.00 (3.39) 2.91 (3.73) 0.945
DLB 1.47 (2.33) 2.86 (2.80) 0.234
Disinhibition
AD 0.34 (1.33) 0.42 (1.43) 0.800 0.822 0.351 0.573
VaD 0.48 (1.54) 0.00 (0.00) 0.171
DLB 0.40 (1.55) 0.00 (0.00) 0.508
Irritability
AD 1.24 (2.60) 2.89 (4.19) 0.110 0.333 0.067 0.443
VaD 1.24 (2.19) 1.36 (2.20) 0.879
DLB 0.60 (1.30) 2.00 (3.46) 0.336
Aberrant motor
behavior
AD 0.88 (2.41) 1.74 (3.12) 0.268 0.037 0.281 0.586
VaD 0.57 (1.57) 0.36 (0.92) 0.690
DLB 1.87 (3.87) 3.00 (4.04) 0.535
Notes: Values are presented as mean (SD).
AD: Alzheimer’s disease; AD without delirium (n = 110), AD with delirium (n = 19).
VaD: Vascular dementia; VaD without delirium (n = 21), VaD with delirium (n = 11).
DLB: Dementia with Lewy bodies; DLB without delirium (n = 15), DLB with delirium (n = 7).
∗p < 0.01; aDLB versus AD or VaD as per Scheffe’s post hoc test.
and utilize instruments that capture characteristics
that differentiate delirium and dementia disorders
(Meagher and Trzepacz, 2007).
In the 263 post-stroke patients of the Helsinki
Stroke Aging Memory cohort study, patients
with delirium were more likely to have pre-
stroke cognitive decline compared with patients
without delirium (28.0% vs. 4.2%), and the
former group developed post-stroke dementia more
frequently than the latter group (50.0% vs. 16.9%;
Melkas et al., 2012). In addition, the findings
of this study suggest that CVD in patients with
neurodegenerative dementias, such as AD and
DLB, are at an increased risk of delirium. However,
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the association of CVD with neurodegenerative
dementia and delirium remains unclear. Delirium
may be a disorder of corticostriatal loops, and
a central cholinergic deficiency may be a major
factor in its development (Robertsson et al.,
1998). In patients with CVD accompanied by
neurodegenerative dementias, the cortex is probably
partly disconnected from deeper structures, and
this causes cortical and subcortical dysfunction and
a decrease in cholinergic activity. Cerebrovascular
disease may be one of the major risk factors causing
vulnerability to delirium.
In this study, NPI scores, particularly agitation
subscale scores, were higher in patients with
delirium than in those without (“pure” dementia).
In a previous study, the scores for a wide range of
DRS-R98 non-cognitive items, such as sleep–wake
cycles, perceptual abnormalities, affective liability,
thought process abnormalities, motor agitation, and
motor retardation, were more severe in patient
groups with dementia and comorbid delirium
than in patient groups with “pure” dementia
(Meagher et al., 2010). Taking into account these
findings, delirium has an additive impact on the
phenomenological profile of patients with dementia.
Delirium has been shown to accelerate the trajectory
of cognitive decline during the follow-up course of
memory-clinic patients with AD (Fong et al., 2009).
In addition, delirium is highly prevalent among
hospitalized patients with AD and is associated
with an increased rate of cognitive deterioration in
these patients (Weiner, 2012). Moreover, delirium
itself is a cause of long-term cognitive impairment.
However, the key question of whether delirium
is a risk factor for new-onset dementia remains
unanswered (MacLullich et al., 2009). In a true
population-based study, delirium has been shown
to be a strong risk factor for the incidence of
dementia and cognitive decline, but the relationship
did not appear to be mediated by the classic
neuropathologies associated with dementia (Davis
et al., 2012). In a longitudinal future study, we
should carefully investigate the relationship between
delirium and onset of dementia.
A previous study demonstrated an increased risk
of admission to long-term care facilities among
patients with delirium superimposed on dementia
than among patients with “pure” dementia or only
delirium (Fick et al., 2002). This study suggests that
delirium superimposed on dementia exaggerates
BPSD and decreases patients’ ADL. Therefore,
delirium superimposed on dementia can become a
major burden to long-term care services.
This study had some limitations. First, we did
not have pathological confirmations of dementia
subtype in our patients. Second, the results may
have been biased because all patients were recruited
from the dementia outpatient clinic of a mental
hospital, and the prevalence of delirium varies
depending on the care settings. Hospital admission
is one of the major risk factors for delirium, and
most previous studies have examined hospitalized
patients. A well-defined dementia cohort in an
outpatient clinic is the strength of our study.
However, taking account of the number of people
with delirium due to medical problems severe
enough to preclude coming to the memory clinic,
the prevalence of delirium with dementia in this
study may estimate low. Third, in order to
identify CVD, we used a visual assessment method
using CT, which may not be as accurate as
assessments conducted using magnetic resonance
imaging (MRI). Fourth, our sample size with regard
to patients with each dementia type was relatively
small for analysis. We had to exclude FTLD and
other types of dementia for statistical analysis.
However, an advantage of our study was the
relatively large study cohort. A future investigation
similar to this one should be conducted with a larger
number of patients.
In summary, the findings of this study suggest
that the frequency of delirium varies among patients
with different types of dementia. In addition, these
findings suggest that delirium decreases ADL,
exaggerates BPSD, and is associated with CVD in
patients with neurodegenerative dementias.
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